+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Rheumatoid Arthritis"

ABC of Rheumatology. Edition No. 5. ABC Series - Product Thumbnail Image

ABC of Rheumatology. Edition No. 5. ABC Series

  • Book
  • April 2018
  • 224 Pages
Vaccines and Autoimmunity. Edition No. 1 - Product Thumbnail Image

Vaccines and Autoimmunity. Edition No. 1

  • Book
  • June 2015
  • 392 Pages
Rheumatology Board Review. Edition No. 1 - Product Thumbnail Image

Rheumatology Board Review. Edition No. 1

  • Book
  • July 2014
  • 224 Pages
Loading Indicator

Rheumatoid Arthritis (RA) is a chronic autoimmune disorder that affects the joints and other organs. It is a type of inflammatory arthritis that is caused by an overactive immune system. RA is a major cause of disability and is the most common form of inflammatory arthritis. It affects people of all ages, but is more common in women than men. Symptoms of RA include joint pain, swelling, stiffness, and decreased range of motion. Treatment for RA includes medications, physical therapy, and lifestyle changes. The RA market within the context of Allergy and Immunology is a rapidly growing market. It is driven by the increasing prevalence of RA, the development of new treatments, and the increasing demand for better treatments. The market is expected to grow due to the increasing awareness of RA and the increasing demand for better treatments. Some companies in the RA market include AbbVie, Amgen, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Johnson & Johnson, Novartis, Pfizer, and Roche. Show Less Read more